Clinical Trial Update: A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD) [Phase 4]

View source ↗

Summary

An update on the safety study of rabeprazole in adults with gastroesophageal reflux disease conducted in Phase 4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Rabeprazole (rabeprazole)

Snippet

Sponsor: Janssen Cilag Pharmaceutica S.A.C.I., Greece | Conditions: Gastroesophageal Reflux, Heartburn | Phase 4 | Status: COMPLETED